Penumbra, Inc. (PEN)
320.86
-0.34
(-0.11%)
USD |
NYSE |
Oct 16, 16:00
319.78
-1.08
(-0.34%)
After-Hours: 20:00
Penumbra Cash from Investing (Quarterly) : -91.09M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -91.09M |
| March 31, 2026 | -30.63M |
| December 31, 2025 | -225.65M |
| September 30, 2025 | -162.86M |
| June 30, 2025 | -15.58M |
| March 31, 2025 | -0.502M |
| December 31, 2024 | -10.96M |
| September 30, 2024 | 35.72M |
| June 30, 2024 | 34.47M |
| March 31, 2024 | 18.38M |
| December 31, 2023 | 24.28M |
| September 30, 2023 | -44.40M |
| June 30, 2023 | -6.671M |
| March 31, 2023 | 10.71M |
| December 31, 2022 | 8.633M |
| September 30, 2022 | 9.786M |
| June 30, 2022 | 20.66M |
| March 31, 2022 | 15.71M |
| December 31, 2021 | -1.339M |
| September 30, 2021 | -49.83M |
| June 30, 2021 | 26.34M |
| March 31, 2021 | 3.09M |
| December 31, 2020 | -10.23M |
| September 30, 2020 | -49.42M |
| June 30, 2020 | -54.54M |
| Date | Value |
|---|---|
| March 31, 2020 | 10.04M |
| December 31, 2019 | -43.43M |
| September 30, 2019 | 14.28M |
| June 30, 2019 | -14.61M |
| March 31, 2019 | 31.86M |
| December 31, 2018 | 9.625M |
| September 30, 2018 | -20.65M |
| June 30, 2018 | 12.82M |
| March 31, 2018 | -2.187M |
| December 31, 2017 | -16.39M |
| September 30, 2017 | -22.10M |
| June 30, 2017 | -29.18M |
| March 31, 2017 | -9.976M |
| December 31, 2016 | 4.207M |
| September 30, 2016 | -3.824M |
| June 30, 2016 | -1.30M |
| March 31, 2016 | 1.604M |
| December 31, 2015 | -129.40M |
| September 30, 2015 | -1.434M |
| June 30, 2015 | 37.48M |
| March 31, 2015 | 7.54M |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | -0.298M |
| March 31, 2014 | -0.642M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp. | -1.956B |
| Teleflex, Inc. | -15.51M |
| Globus Medical, Inc. | -129.05M |
| Integra LifeSciences Holdings Corp. | -43.28M |
| Abbott Laboratories | -673.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 46.08M |
| Cash from Financing (Quarterly) | 9.025M |
| Free Cash Flow | 215.91M |
| Free Cash Flow Per Share (Quarterly) | 0.8223 |
| Free Cash Flow to Equity (Quarterly) | 36.01M |
| Free Cash Flow to Firm (Quarterly) | 32.78M |
| Free Cash Flow Yield | 1.71% |